East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. Aurobindo Pharma’s Adapalene and Benzoyl Peroxide Topical Gel,  are an AB-rated generic equivalent to the reference listed drug (RLD), Epiduo® Forte Topical Gel, manufactured by Galderma Laboratories, L.P.

Adapalene and Benzoyl Peroxide Topical Gel are indicated for the:

• Topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older.